| Timothy Day, MD | |
|
540 Hospital Dr, Winamac, IN 46996-1173 | |
| (574) 946-2194 | |
| Not Available |
| Full Name | Timothy Day |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 7 Years |
| Location | 540 Hospital Dr, Winamac, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386178861 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 01082505A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Angels Of Mercy Homecare | Marion, IN | Home health agency |
| Pulaski Memorial Hospital | Winamac, IN | Hospital |
| Saint Joseph Regional Medical Center - Plymouth | Plymouth, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pulaski Memorial Hospital | 3173515509 | 29 |
News Archive
Wolters Kluwer, a market leader in the professional health content and clinical decision support market, today announced a plan to divest its Pharma-related business. The company is well-positioned to benefit from healthcare reform trends globally to support the Health division's growth strategy.
A study published in today's British Medical Journal suggests that banning smoking in a community can result in an almost immediate drop-off in the number of heart attacks in that community. The study, which was originally presented at the 52nd Annual College of Cardiology Scientific Session in 2003, examined the number of people in Helena, Mont., who were admitted to the hospital for a heart attack before, during and after a local ordinance banned smoking in public and workplaces.
The unprecedented move comes after data released today showed the worst ever four-hour emergency care performance at just 76.9% at major emergency departments. Sitrep data also showed that in February bed occupancy was at 95.1%.
Two pacemakers in the brain work together in harmony to ensure that breathing occurs in a regular rhythm, according to new research from MIT scientists.
InterMune, Inc. announced today that the U.S. Food and Drug Administration (FDA) has posted briefing documents for the March 9 Pulmonary-Allergy Drugs Advisory Committee (PADAC) meeting to review the New Drug Application (NDA) for pirfenidone, InterMune's investigational drug candidate for the treatment of patients with idiopathic pulmonary fibrosis (IPF) to reduce decline in lung function. The proposed trade name for pirfenidone is Esbriet®.
› Verified 4 days ago
| Entity Name | Pulaski Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740403419 PECOS PAC ID: 3173515509 Enrollment ID: O20040402000963 |
News Archive
Wolters Kluwer, a market leader in the professional health content and clinical decision support market, today announced a plan to divest its Pharma-related business. The company is well-positioned to benefit from healthcare reform trends globally to support the Health division's growth strategy.
A study published in today's British Medical Journal suggests that banning smoking in a community can result in an almost immediate drop-off in the number of heart attacks in that community. The study, which was originally presented at the 52nd Annual College of Cardiology Scientific Session in 2003, examined the number of people in Helena, Mont., who were admitted to the hospital for a heart attack before, during and after a local ordinance banned smoking in public and workplaces.
The unprecedented move comes after data released today showed the worst ever four-hour emergency care performance at just 76.9% at major emergency departments. Sitrep data also showed that in February bed occupancy was at 95.1%.
Two pacemakers in the brain work together in harmony to ensure that breathing occurs in a regular rhythm, according to new research from MIT scientists.
InterMune, Inc. announced today that the U.S. Food and Drug Administration (FDA) has posted briefing documents for the March 9 Pulmonary-Allergy Drugs Advisory Committee (PADAC) meeting to review the New Drug Application (NDA) for pirfenidone, InterMune's investigational drug candidate for the treatment of patients with idiopathic pulmonary fibrosis (IPF) to reduce decline in lung function. The proposed trade name for pirfenidone is Esbriet®.
› Verified 4 days ago
| Entity Name | Pulaski Memorial Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1306928213 PECOS PAC ID: 3173515509 Enrollment ID: O20071214000021 |
News Archive
Wolters Kluwer, a market leader in the professional health content and clinical decision support market, today announced a plan to divest its Pharma-related business. The company is well-positioned to benefit from healthcare reform trends globally to support the Health division's growth strategy.
A study published in today's British Medical Journal suggests that banning smoking in a community can result in an almost immediate drop-off in the number of heart attacks in that community. The study, which was originally presented at the 52nd Annual College of Cardiology Scientific Session in 2003, examined the number of people in Helena, Mont., who were admitted to the hospital for a heart attack before, during and after a local ordinance banned smoking in public and workplaces.
The unprecedented move comes after data released today showed the worst ever four-hour emergency care performance at just 76.9% at major emergency departments. Sitrep data also showed that in February bed occupancy was at 95.1%.
Two pacemakers in the brain work together in harmony to ensure that breathing occurs in a regular rhythm, according to new research from MIT scientists.
InterMune, Inc. announced today that the U.S. Food and Drug Administration (FDA) has posted briefing documents for the March 9 Pulmonary-Allergy Drugs Advisory Committee (PADAC) meeting to review the New Drug Application (NDA) for pirfenidone, InterMune's investigational drug candidate for the treatment of patients with idiopathic pulmonary fibrosis (IPF) to reduce decline in lung function. The proposed trade name for pirfenidone is Esbriet®.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Timothy Day, MD Po Box 279, Winamac, IN 46996-0279 Ph: (574) 946-2194 | Timothy Day, MD 540 Hospital Dr, Winamac, IN 46996-1173 Ph: (574) 946-2194 |
News Archive
Wolters Kluwer, a market leader in the professional health content and clinical decision support market, today announced a plan to divest its Pharma-related business. The company is well-positioned to benefit from healthcare reform trends globally to support the Health division's growth strategy.
A study published in today's British Medical Journal suggests that banning smoking in a community can result in an almost immediate drop-off in the number of heart attacks in that community. The study, which was originally presented at the 52nd Annual College of Cardiology Scientific Session in 2003, examined the number of people in Helena, Mont., who were admitted to the hospital for a heart attack before, during and after a local ordinance banned smoking in public and workplaces.
The unprecedented move comes after data released today showed the worst ever four-hour emergency care performance at just 76.9% at major emergency departments. Sitrep data also showed that in February bed occupancy was at 95.1%.
Two pacemakers in the brain work together in harmony to ensure that breathing occurs in a regular rhythm, according to new research from MIT scientists.
InterMune, Inc. announced today that the U.S. Food and Drug Administration (FDA) has posted briefing documents for the March 9 Pulmonary-Allergy Drugs Advisory Committee (PADAC) meeting to review the New Drug Application (NDA) for pirfenidone, InterMune's investigational drug candidate for the treatment of patients with idiopathic pulmonary fibrosis (IPF) to reduce decline in lung function. The proposed trade name for pirfenidone is Esbriet®.
› Verified 4 days ago
Clinton L. Kauffman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 540 Hospital Dr, Winamac, IN 46996 Phone: 574-946-2194 Fax: 574-946-2196 | |
Dr. Brian Alan Johnson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 613 Terrace Dr, Winamac, IN 46996 Phone: 574-946-6644 Fax: 574-946-7801 | |
Mr. Charles Edward Heinsen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 129 E Pearl St, Winamac, IN 46996 Phone: 574-205-5015 Fax: 574-205-5014 | |
Dr. Michael Ryan Keller, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 540 Hospital Dr, Winamac, IN 46996 Phone: 574-946-2194 | |
Melissa D Zahrt, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 616 E 13th St, Winamac, IN 46996 Phone: 574-946-2194 Fax: 574-946-2196 | |
Mr. Paul John Russo, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 222 S Monticello St, Winamac, IN 46996 Phone: 574-946-3245 Fax: 574-946-3383 |